Peripapillary and Macular OCTA Predictors of Visual Improvement in Patients Treated with Vitrectomy for Idiopathic Epiretinal Membrane [0.03%]
玻璃体切割治疗特发性黄斑内界膜皱褶的患者的视力改善的视网膜血管成像预测因素
Elvia Mastrogiuseppe,Giacomo Visioli,Giuseppe Maria Albanese et al.
Elvia Mastrogiuseppe et al.
Introduction: We investigated the changes of peripapillary and macular microvasculature in idiopathic macular epiretinal membrane (iERM) eyes before and after pars plana vitrectomy (PPV), aiming to identify potential opti...
Early Changes in Ocular Biomarkers in Patients with Vogt-Koyanagi-Harada Disease after Pulse Steroid Therapy [0.03%]
脉冲皮质类固醇治疗 vogt-小柳-原田病患者的早期眼生物标志物变化
Tetsuya Muto,Shunsuke Kawaguchi,Shoichiro Kusuda et al.
Tetsuya Muto et al.
Introduction: This study aimed to identify when ocular biomarker changes occur within 1 month and which ocular biomarkers correlate with best-corrected visual acuity (BCVA) at months 1 and 6. ...
Dealing with the Verteporfin Shortage: Treatment Options and Outcomes in Patients with Chronic and Non-Resolving Central Serous Chorioretinopathy [0.03%]
关于verteporfin短缺的处理：慢性及顽固性中心性浆液性脉络膜视网膜病变患者的治疗选择和预后
Femke M van den Tillaart,Franca Hartgers,Carel B Hoyng et al.
Femke M van den Tillaart et al.
Introduction: Half-dose photodynamic therapy (HD-PDT) with verteporfin is the mainstay treatment in central serous chorioretinopathy (CSC). Since 2021, there is a worldwide shortage of verteporfin. This called for adjustm...
Advancing the Frontiers of Retinal Vasculitis: Insights, Challenges, and Future Directions [0.03%]
视网膜血管炎的前沿进展：洞察、挑战与未来方向
Marion R Munk,Emmett T Cunningham Jr
Marion R Munk
Efficacy and Safety of Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion: A Meta-Analysis [0.03%]
法西莫单抗治疗脉络膜新生血管性年龄相关性黄斑变性和糖尿病黄斑水肿及视网膜静脉阻塞疗效和安全性的meta分析
Prem A H Nichani,Marko M Popovic,Andrew Mihalache et al.
Prem A H Nichani et al.
Introduction: Intravitreal anti-vascular endothelial growth factor (VEGF) therapy has become the mainstay of treatment in many retinal diseases. The comparative efficacy and safety of newer bispecific anti-VEGF/angiopoiet...
Baseline Features in Polypoidal Choroidal Vasculopathy in Caucasian Patients [0.03%]
高加索人视网膜脉络膜血管病变的基线特征
Maria Ludovica Ruggeri,Lisa Toto,Rossella D&#x;Aloisio et al.
Maria Ludovica Ruggeri et al.
Introduction: The aim of this study was to investigate demographic, anatomical, angiographic, and functional parameters in patients suffering from polypoidal choroidal vasculopathy (PCV). ...
Changes of Optical Coherence Tomography Biomarkers after Peeling of Epiretinal Membranes [0.03%]
黄斑前膜剥除术后的光学相干断层扫描生物标志物变化特征分析
Christoph Leisser,Andreas Schlatter,Manuel Ruiss et al.
Christoph Leisser et al.
Introduction: Several optical coherence tomography (OCT) biomarkers for postsurgical success among patients with idiopathic epiretinal membranes (iERMs) undergoing pars plana vitrectomy and membrane peeling have been desc...
Matias Iglicki,Dinah Zur
Matias Iglicki
Atul Arora,Manisha Agarwal,Nicholas Chieh Loh et al.
Atul Arora et al.
Background: Retinal vasculitis has heterogeneous etiologies encompassing infections, autoimmune diseases, masquerades, and idiopathic causes. The heterogeneity in the underlying clinical features and etiologies of retinal...
Clinical and Demographic Characteristics of Treatment Requiring Retinopathy of Prematurity in Big Premature Infants in Turkiye: Report No. 1 (BIG-ROP Study) [0.03%]
土耳其特大早产儿需要治疗的视网膜病变的临床和人口学特征：第1号报告（特大-ROP研究）
Şengül Özdek,Huseyin Baran Ozdemir,Zuhal Ozen Tunay et al.
Şengül Özdek et al.
Introduction: The aim of the study was to analyse the clinical and demographic features of infants with gestational age (GA) of 32-37 weeks and birth weight (BW) of >1,500 g who developed treatment requiring retinopathy o...